| Multiple Myeloma |
1 |
0.92 |
| Proteasome Inhibitor |
0 |
0.81 |
| Thromboembolism |
0 |
0.68 |
| Renal Failure |
0 |
0.65 |
| Platelet Count |
0 |
0.55 |
| Genomic Medicine |
0 |
0.47 |
| Thrombocytopenia |
0 |
0.46 |
| Stem Cell Research and Therapy |
0 |
0.45 |
| Biologic Therapy |
0 |
0.35 |
| Blood |
0 |
0.32 |
| End-Stage Renal Disease |
0 |
0.28 |
| Plasma |
0 |
0.28 |
| Hemodialysis |
0 |
0.24 |
| Genetic Testing |
0 |
0.23 |
| Hemolytic Anemia |
0 |
0.2 |
| Toxicology |
0 |
0.2 |
| Fractures |
0 |
0.17 |
| Anemia |
0 |
0.16 |
| Genetics |
0 |
0.16 |
| Cell Transplantation |
0 |
0.14 |
| Disseminated Intravascular Coagulation |
0 |
0.14 |
| Influenza |
0 |
0.14 |
| Wound Management |
0 |
0.14 |
| Hemoglobin |
0 |
0.12 |
| Immunomodulator |
0 |
0.12 |
| Polymerase Chain Reaction |
0 |
0.12 |
| Transplantation |
0 |
0.12 |
| Aspirin |
0 |
0.08 |
| Fever |
0 |
0.08 |
| Hemolysis |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Immunoglobulin G (IgG) |
0 |
0.08 |
| Injury |
0 |
0.08 |
| Steroids |
0 |
0.08 |
| Vitamin |
0 |
0.08 |
| Wisconsin |
0 |
0.08 |
| Cardiovascular Risk Management |
0 |
0.07 |
| Chest X-ray |
0 |
0.07 |
| Diarrhea |
0 |
0.07 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Lipids Management |
0 |
0.07 |
| Osteoarthritis |
0 |
0.07 |
| Atypical Hemolytic Uremic Syndrome |
0 |
0.06 |
| Monoclonal Gammopathies of Uncertain Origin |
0 |
0.06 |
| Thrombotic Thrombocytopenic Purpura |
0 |
0.06 |
| Calcium |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Coagulation |
0 |
0.04 |
| Edema |
0 |
0.04 |
| Escherichia coli |
0 |
0.04 |
| Fatty Acids |
0 |
0.04 |
| Fish Oil |
0 |
0.04 |
| Hemolytic Uremic Syndrome |
0 |
0.04 |
| Hypnotic Drug |
0 |
0.04 |
| Leukocytosis |
0 |
0.04 |
| Microbicides |
0 |
0.04 |
| Monoclonal Gammopathy |
0 |
0.04 |
| Nausea |
0 |
0.04 |
| Neutrophils |
0 |
0.04 |
| Patient History |
0 |
0.04 |
| Refractory |
0 |
0.04 |
| Thorax |
0 |
0.04 |
| Thrombocytopenic Purpura |
0 |
0.04 |
| Thrombosis |
0 |
0.04 |
| Urinalysis |
0 |
0.04 |
| Viral Infection |
0 |
0.04 |
| X-ray |
0 |
0.04 |